VivoPower has essentially no institutional sell-side coverage. Rather than a broad analyst consensus, the only price objective visible across major aggregators is a single target of $10.00, attributed to one analyst. With only one verifiable estimate and no identifiable range, high/low spread, or distribution of bullish versus cautious views, it is not possible to calculate a meaningful average analyst price target for this stock.
For that reason, the $10.00 figure in this article is treated as a limited-coverage, single-analyst objective rather than a published consensus, and it should be read with considerable caution. The absence of multiple firm-dated targets means there is no reliable picture of how bullish, neutral, or bearish opinions differ among analysts. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
At a recent price of about $2.21, reaching $10.00 would require a gain of approximately 350%, a very large move by any conventional measure. The stock trades near the lower half of its 52-week range of $1.20 to $6.86 and below both its 50-day moving average of roughly $3.41 and its 200-day moving average of roughly $3.45, indicating a pronounced downtrend from earlier highs.
The path to $10 would first require reclaiming the $3.00–$3.50 zone and then clearing the $6.86 prior high before any advance toward double digits could even be contemplated. For context, VivoPower reported trailing revenue of only about $61,000 with a net loss of roughly $19 million, so the business is still pre-revenue in any meaningful commercial sense relative to its ambitions.
The most credible support comes from the company's strategic repositioning. Its narrative centers on converting land and energy assets into "Power-to-X" infrastructure serving sovereign AI and data center demand, a theme that has attracted speculative investor interest. If management can convert its data-center pipeline into signed contracts and begin recognizing material revenue, sentiment toward the stock could improve substantially. With a public float of only about 7.2 million shares, any positive catalyst can also produce outsized price moves.
The obstacles are substantial. VivoPower is generating negligible revenue, posting negative earnings per share (EPS) and negative operating cash flow, and carrying roughly $29 million in debt against about $60,000 in cash, with a total debt-to-equity ratio near 190%. The company also faces meaningful dilution risk given its need for capital. Short interest of roughly 7% of the float and a negative beta reflect both skepticism and unusual trading dynamics. Until the company demonstrates genuine, contracted revenue, the gap between the current share price and any double-digit objective is likely to remain wide.
The 52-week high of $6.86 is the most significant resistance level, since $10.00 lies well above it. Nearer-term resistance sits around $3.00–$3.50, aligned with the 50-day and 200-day moving averages. On the downside, the $2.00 area has acted as a recent support zone, with the 52-week low at $1.20. The $10 target therefore represents not a measured extension of an established uptrend but a breakout scenario that would require the stock to roughly quadruple and set new all-time highs. From what I see, the technical setup remains challenging until key resistance levels are cleared.
Price targets generally reflect a research horizon, often around 12 months, though the exact horizon for the single $10 estimate is not disclosed. Investors should watch the next earnings report, estimated for November 23, 2026, as well as any announcements of signed data center or energy contracts, funding or dilution events, and changes in short interest. Because coverage is so thin, any new analyst initiation or target revision would be disproportionately important to the stock forecast. I’m watching this closely for any signs of contract momentum.
In my research process, Tickeron’s AI Daily Buy/Sell Signals provide a useful way to monitor volatile names like this one. The tool applies artificial intelligence to scan thousands of stocks and ETFs, producing Buy, Sell, or Hold signals based on technical behavior and shifting market conditions. For thinly covered stocks, it helps surface potential turning points more efficiently than manual checks alone. I find it particularly helpful for tracking trend changes in real time.
The question of whether VivoPower can reach $10 is best understood against the reality that this target reflects a single analyst's view, not a broad consensus, and that it implies a roughly 350% advance from a price near $2.21. The strongest supports are the company's AI and sovereign-data-center narrative and its low float, while the principal obstacles are minimal revenue, negative earnings, high leverage, and a pronounced downtrend. With no meaningful analyst coverage and no durable technical foundation beneath the target, the $10 objective should be regarded as a speculative, high-risk scenario rather than a near-term expectation. Investors should monitor the earnings report, contract announcements, and any new analyst coverage before drawing conclusions.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
VIVO may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 38 of 42 cases where VIVO's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 90%.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where VIVO's RSI Oscillator exited the oversold zone, 30 of 36 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 83%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 56 of 64 cases where VIVO's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 88%.
The Momentum Indicator moved above the 0 level on October 27, 2026. You may want to consider a long position or call options on VIVO as a result. In 67 of 81 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 83%.
The Moving Average Convergence Divergence (MACD) for VIVO just turned positive on October 27, 2026. Looking at past instances where VIVO's MACD turned positive, the stock continued to rise in 37 of 46 cases over the following month. The odds of a continued upward trend are 80%.
Following a +15.10% 3-day Advance, the price is estimated to grow further. Considering data from situations where VIVO advanced for three days, in 186 of 222 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.
VIVO moved below its 50-day moving average on September 28, 2026 date and that indicates a change from an upward trend to a downward trend.
The 50-day moving average for VIVO moved below the 200-day moving average on October 29, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where VIVO declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for VIVO entered a downward trend on November 02, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 12 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 86 (best 1 - 100 worst), indicating slightly worse than average price growth. VIVO’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 96 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.192) is normal, around the industry mean (16.593). P/E Ratio (-1.148) is within average values for comparable stocks, (57.337). Projected Growth (PEG Ratio) (0.220) is also within normal values, averaging (3.648). Dividend Yield (0.000) settles around the average of (0.283) among similar stocks. P/S Ratio (769.231) is also within normal values, averaging (103.889).
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. VIVO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a manufacturer of diagnostic products
Industry ComputerCommunications